40 min listen
Emerging Long-Acting PrEP Options
ratings:
Length:
15 minutes
Released:
Sep 16, 2021
Format:
Podcast episode
Description
In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.Presenter:Colleen Kelley, MD, MPHAtlanta, Georgia Colleen Kelley, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, Moderna, Novavax, and ViiV Healthcare. Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/3AFvsZY
Released:
Sep 16, 2021
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 1: In Part 1 of this ongoing 12-part COVID-19 series, listen to a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data on evidence-based antiviral therapy for severe disease followed by answers to critical clinician questions on COVID-19 transmission, diagnosis, and management from frontline provider Vikramjit Mukherjee, MD. by CCO Infectious Disease Podcast